This study aimed to determine if capillary rarefaction is detectable and associated with endothelial dysfunction in persons with mild systolic blood pressure (SBP) elevation. Capillary density and endothelial function were quantified for 150 nondiabetic participants, grouped by blood pressure (BP) as normotensive, untreated high BP, and treated high BP. Structural capillary rarefaction measures were not different between the three groups. Functional capillary rarefaction measures were significantly lower in both high BP groups compared to normotensives, and correlated inversely with endothelial function. The study findings indicate that the hypertensive vascular pathologic process is already underway at modest levels of blood pressure elevation.
Antonios, T.F. (2006) Microvascular rarefaction in hypertension-reversal or over-correction by treatment? Am J Hypertens19: 484-485.
2.
Antonios, T.F., Singer, D.R., Markandu, N.D., Mortimer, P.S. and MacGregor, G.A. (1999a) Structural skin capillary rarefaction in essential hypertension. Hypertension33: 998-1001.
3.
Antonios, T.F., Singer, D.R., Markandu, N.D., Mortimer, P.S. and MacGregor, G.A. (1999b) Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormalityHypertension34(4 Pt 1): 655-658.
4.
Antonios, T.F., Rattray, F.E., Singer, D.R., Markandu, N.D., Mortimer, P.S. and MacGregor, G.A. (1999c) Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin Sci (Lond)97: 523-528.
5.
Antonios, T.F., Rattray, F.M., Singer, D.R., Markandu, N.D., Mortimer, P.S. and MacGregor, G.A. (2003) Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart89: 175-178.
6.
Battegay, E.J., de Miguel, L.S., Petrimpol, M. and Humar, R.(2007) Effects of anti-hypertensive drugs on vessel rarefaction. Curr Opin Pharmacol7: 151-157.
7.
Bonetti, P.O., Lerman, L.O. and Lerman, A. (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol23: 168-175.
8.
Carpentier, P.H. (1999) New techniques for clinical assessment of the peripheral microcirculationDrugs59 Spec: 17-22.
9.
Cohn, J.N. (2007) Is it the blood pressure or the blood vessel? Journal of the American Society of Hypertension1: 5-16.
10.
Davignon, J. and Ganz, P. (2004) Role of endothelial dysfunction in atherosclerosis . Circulation109(23 Suppl 1): I1127-I1132.
11.
Debbabi, H., Uzan, L., Mourad, J.J., Safar, M., Levy, B.I. and Tibirica, E. (2006) Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens19: 477-483.
12.
Feihl, F., Liaudet, L., Waeber, B. and Levy, B.I. (2006) Hypertension: a disease of the microcirculation ? Hypertension48: 1012-1017.
13.
Gasser, P. and Buhler, F.R. (1992) Nailfold microcirculation in normotensive and essential hypertensive subjects, as assessed by video-microscopy. J Hypertens10: 83-86.
14.
Higashi,Y., Sasaki, S., Nakagawa, K., Matsuura, H., Kajiyama, G. and Oshima, T. (2001) A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans . Am J Cardiol87: 121-125, A9.
15.
Higashi,Y. andYoshizumi, M. (2003) New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain-gauge plethysmography: nitric oxide-dependent and independent vasodilation. J Pharmacol Sci93: 399-404.
16.
Ikram, M.K., Witteman, J.C., Vingerling, J.R., Breteler, M.M., Hofman, A. and de Jong, P.T. (2006) Retinal vessel diameters and risk of hypertension: the Rotterdam Study. Hypertension47: 189-194.
17.
JNC 7 Express (2003) The Seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure Publication No. 03-5233, National Institutes of Health, Washington, DC.
18.
Julius, S., Nesbitt, S.D., Egan, B.M., Weber, M.A., Michelson, E.L., Kaciroti, N. et al. (2006) Trial of Preventing Hypertension (TROPHY) Study Investigators Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med354: 1685-1697.
19.
Kannel, W.B. and Higgins, M. (1990) Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens Suppl8: S3-s8.
20.
Levy, B.I., Ambrosio, G., Pries, A.R. and Struijker-Boudier, H.A. (2001) Microcirculation in hypertension: a new target for treatment? Circulation104: 735-740.
21.
Lind, L., Sarabi, M. and Millgard, J. (1998) Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm. Clin Physiol18: 81-87.
22.
Liszka, H.A., Mainous, A.G. 3rd, King, D.E., Everett, C.J. and Egan, B.M. (2005) Prehypertension and cardiovascular morbidity. Ann Fam Med3: 294-299.
23.
Noon, J.P., Walker, B.R., Webb, D.J., Shore, A.C., Holton, D.W., Edwards, H.V. et al. (1997) Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest99: 1873-1879.
24.
Norrelund, H., Christensen, K.L., Samani, N.J., Kimber, P., Mulvany, M.J. and Korsgaard, N. (1994). Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension24: 301-308.
25.
O'Donnell, C.J., Ridker, P.M., Glynn, R.J., Berger, K., Ajani, U., Manson, J.E. et al. (1997) Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation95: 1132-1137.
26.
Pasimeni, G., Ribaudo, M.C., Capoccia, D., Rossi, F., Bertone, C., Leonetti, F. et al. (2006) Non-invasive evaluation of endothelial dysfunction in uncomplicated obesity: relationship with insulin resistance. Microvasc Res71: 115-120.
27.
Poredos, P. (2002) Endothelial dysfunction and cardiovascular disease . Pathophysiol Haemost Thromb32: 274-277.
28.
Prewitt, R.L., Chen, I.I. and Dowell, R. (1982) Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol243: H243-H251.
29.
Raitakari, O.T. and Celermajer, D.S. (2000) Testing for endothelial dysfunction. Ann Med32: 293-304.
30.
Rizzoni, D., Porteri, E., Boari, G.E., De Ciuceis, C., Sleiman, I., Muiesan, M.L. et al. (2003) Prognostic significance of small-artery structure in hypertension. Circulation108: 2230-2235.
31.
Schram, M.T., Schalkwijk, C.G., Bootsma, A.H., Fuller, J.H., Chaturvedi, N. and Stehouwer, C.D. (2005) EURODIAB Prospective Complications Study Group.Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res37 (Suppl 1): 49-55.
32.
Serne, E.H., Gans, R.O., ter Maaten, J.C., Tangelder, G.J., Donker, A.J. and Stehouwer, C.D. (2001) Impaired skin capillary recruitment in essential high blood pressure is caused by both perfused and structural capillary rarefaction . Hypertension38: 238-242.
33.
Serne, E.H., Stehouwer, C.D., ter Maaten, J.C., ter Wee, P.M., Rauwerda, J.A., Donker, A.J. et al. (1999) Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation99: 896-902.
34.
Shore, A.C. (2000) Capillaroscopy and the measurement of capillary pressure. Br J Clin Pharmacol50: 501-513.
35.
Sivertsson, R. (1970) The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol Scan Suppl343: 1-56.
36.
Smith, W., Wang, J.J., Wong, T.Y., Rochtchina, E., Klein, R., Leeder, S.R. et al. (2004) Retinal arteriolar narrowing is associated with 5-year incident severe hypertension: the Blue Mountains Eye Study. Hypertension44: 442-447.
37.
Tousoulis, D., Antoniades, C. and Stefanadis, C. (2005) Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques. Heart91: 553-558.
38.
Vasan, R.S., Larson, M.G., Leip, E.P., Evans, J.C., O'Donnell, C.J., Kannel, W.B. et al. (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. New Engl J Med345: 1291-1297.
39.
Vicaut, E. (1999) Microcirculation and arterial hypertension. Drugs59 Spec No: 1-10.
40.
Wang, J.J., Mitchell, P., Leung, H., Rochtchina, E., Wong, T.Y. and Klein, R. (2003) Hypertensive retinal vessel wall signs in a general older population: the Blue Mountains Eye Study. Hypertension42: 534-541.
41.
Widlansky, M.E., Gokce, N., Keaney, J.F. Jr. and Vita, J.A. (2003) The clinical implications of endothelial dysfunction . J Am Coll Cardiol42: 1149-1160.
42.
Witt, N., Wong, T.Y., Hughes, A.D., Chaturvedi, N., Klein, B.E., Evans, R. et al. (2006) Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension47: 975-981.
43.
Wolf, S., Arend, O., Schulte, K., Ittel, T.H. and Reim, M. (1994) Quantification of retinal capillary density and flow velocity in patients with essential hypertension. Hypertension23: 464-467.
44.
Wong, T.Y., Klein, R., Sharrett, A.R., Schmidt, M.I., Pankow, J.S., Couper, D.J. et al. ARIC Investigators (2002) Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA287: 2528-2533.
